Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-β1/Smad signaling pathways

References

• Derynck R, RJ A, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet. 2001;29:117–129.
   Google Scholar
• Massagué J. TGF-beta signal transduction. Annu Rev Biochem. 1998;67:753–791.
   Google Scholar
• Kajdaniuk D, Marek B, Borgiel-Marek H, et al. Transforming growth factor β1 (TGFβ1) in physiology and pathology. Endokrynol Pol. 2013;64:384–396.
   Google Scholar
• López-Novoa JM, Nieto MA. Inflammation and EMT: an alliance towards organ fibrosis and cancerprogression. EMBO Mol Med. 2009;1:303–314.
   Google Scholar
• Derynck R, YE Z. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425((6958):):577–584.
   Google Scholar
• Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704–715.
   Google Scholar
• Padua D, Massagué J. Roles of TGFbeta in metastasis. Cell Res. 2009;19((1):):89–102.
   Google Scholar
• Baek SH, Ko JH, Lee JH, et al. Ginkgolic acid inhibits invasion and migration and TGF-β-induced EMT of lungcancer cells through PI3K/Akt/mTOR inactivation. J Cell Physiol. 2017;232(2):346–354.
   Google Scholar
• Zhao X, Wu X, Qian M, et al. Knockdown of TGF-β1 expression in human umbilical cord mesenchymal stem cells reverts their exosome-mediated EMT promoting effect on lung cancer cells. Cancer Lett. 2018;428:34–44.
   Google Scholar
• Jeon MJ, Kim WG, Lim S, et al. Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition ofthyroid cancer cells. Mol Cell Endocrinol. 2016;419:113–123.
   Google Scholar
• Pirozzi G, Tirino V, Camerlingo R, et al. Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line. PLoS One. 2011;6(6):e21548.
   Google Scholar
• Sun W, Xu Y, Zhao C, et al. Targeting TGF-β1 suppresses survival of and invasion by anaplastic thyroidcarcinoma cells. Am J Transl Res. 2017;9(3):1418–1425.
   Google Scholar
• Zhang K, Liu X, Hao F, et al. Targeting TGF-β1 inhibits invasion of anaplastic thyroid carcinoma cell through SMAD2-dependent S100A4-MMP-2/9 signalling. Am J Transl Res. 2016;8(5):2196–2209.
   Google Scholar
• Vasko V, Espinosa AV, Scouten W, et al. Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci U S A. 2007;104:2803–2808.
   Google Scholar
• Zhang X, Liu L, Deng X, et al. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells. Oncogene. 2019;38(5):699–715.
   Google Scholar
• Stauber AJ, Credille KM, Truex LL, et al. Nonclinical safety evaluation of a transforming growth factor β receptor I kinase inhibitor in Fischer 344 rats and beagle dogs. J Clin Toxicol. 2014;4:196.
   Google Scholar
• Anderton MJ, Mellor HR, Bell A, et al. Induction of heart valve lesions by small-molecule ALK5 inhibitors. Toxicol Pathol. 2011;39(6):916–924.
   Google Scholar
• Khan N, Afaq F, Saleem M, et al. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res. 2006;66(5):2500–2505.
   Google Scholar
• Negri A, Naponelli V, Rizzi F, et al. Molecular targets of epigallocatechin-gallate (EGCG): a special focus onsignal transduction and cancer. Nutrients. 2018;10(12):1012–1016.
   Google Scholar
• Chang JZ, Hsieh YP, Lin WH, et al. Activation of transforming growth factor-β1 by thrombin via integrins αvβ1, αvβ3, and αvβ5 in buccal fibroblasts: suppression by epigallocatechin-3-gallate. Head Neck. 2017;39(7):1436–1445.
   Google Scholar
• Wang Y, Liu N, Su X, et al. Epigallocatechin-3-gallate attenuates transforming growth factor-β1 induced epithelial-mesenchymal transition via Nrf2 regulation in renal tubular epithelial cells. Biomed Pharmacother. 2015;70:260–267.
   Google Scholar
• Ko H, So Y, Jeon H, et al. TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human lung cancer cells. Cancer Lett. 2013;335(1):205–213.
   Google Scholar
• De Amicis F, Perri A, Vizza D, et al. Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines. J Cell Physiol. 2013;228(10):2054–2062.
   Google Scholar
• Dopeso H, Jiao HK, Cuesta AM, et al. PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFα. Cancer Res. 2018;78(7):1805–1819.
   Google Scholar
• Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol. 2003;15(6):740–746.
   Google Scholar
• Vosgha H, Ariana A, RA S, et al. miR-205 targets angiogenesis and EMT concurrently in anaplastic thyroid carcinoma. Endocr Relat Cancer. 2018;25(3):323–337.
   Google Scholar
• Braun J, Hoang-Vu C, Dralle H, et al. Downregulation of microRNAs directs the EMT and invasive potential ofanaplastic thyroid carcinomas. Oncogene. 2010;29(29):4237–4244.
   Google Scholar
• Massague J, Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. Embo J. 2000;19:1745–1754.
   Google Scholar
• Gan RY, Li HB, Sui ZQ, et al. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): an updated review. Crit Rev Food Sci Nutr. 2018;58(6):924–941.
   Google Scholar
• Negri A, Naponelli V, Rizzi F, et al. Targets of epigallocatechin-gallate (EGCG): a special focus on signal transduction and cancer. Nutrients. 2018;10(12):E1936.
   Google Scholar
• Belguise K, Guo S, Sonenshein GE. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. Cancer Res. 2007;67(12):5763–5770.
   Google Scholar
• Liu LC, Tsao TC, Hsu SR, et al. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells. J Agric Food Chem. 2012;60(39):9863–9873.
   Google Scholar
• Yang MH, Kim J, Khan IA, et al. Nonsteroidal anti-inflammatory drug activated gene-1 (NAG-1) modulators from natural products as anti-cancer agents. Life Sci. 2014;100:75–84.
   Google Scholar
• Zhong Y, Krisanapun C, Lee SH, et al. Molecular targets of apigenin in colorectal cancer cells: involvement of p21, NAG-1 and p53. Eur J Cancer. 2010;46:3365–3374.
   Google Scholar
• Xue H, Lu B, Zhang J, et al. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J Proteome Res. 2010;9:545–555.
   Google Scholar
• Senapati S, Rachagani S, Chaudhary K, et al. Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway. Oncogene. 2010;29:1293–1302.
   Google Scholar
• Blanco-Calvo M, Tarrio N, Reboredo M, et al. Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer. Future Oncol. 2014;10:1187–1202.
   Google Scholar